title: Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.
abstract: To develop adriamycin (ADM)-encapsulated poly(lactic-co-glycolic acid) (PLGA) nanoparticles in a porous nano-hydroxyapatite/collagen scaffold (ADM-PLGA-NHAC). To provide novel strategies for future treatment of osteosarcoma, the properties of the scaffold, including its in vitro extended-release properties, the inhibition effects of ADM-PLGA-NHAC on the osteosarcoma MG63 cells, and its bone repair capacity, were investigated in vivo and in vitro. The PLGA copolymer was utilized as a drug carrier to deliver ADM-PLGA nanoparticles (ADM-PLGA-NP). Porous nano-hydroxyapatite and collagen were used to materials to produce the porous nano-hydroxyapatite/collagen scaffold (NHAC), into which the ADM-PLGA-NP was loaded. The performance of the drug-carrying scaffold was assessed using multiple techniques, including scanning electron microscopy and in vitro extended release. The antineoplastic activities of scaffold extracts on the human osteosarcoma MG63 cell line were evaluated in vitro using the cell counting kit-8 (CCK8) method and live-dead cell staining. The bone repair ability of the scaffold was assessed based on the establishment of a femoral condyle defect model in rabbits. ADM-PLGA-NHAC and NHAC were implanted into the rat muscle bag for immune response experiments. A tumor-bearing nude mice model was created, and the TUNEL and HE staining results were observed under optical microscopy to evaluate the antineoplastic activity and toxic side effects of the scaffold. The composite scaffold demonstrated extraordinary extended-release properties, and its extracts also exhibited significant inhibition of the growth of osteosarcoma MG63 cells. In the bone repair experiment, no significant difference was observed between ADM-PLGA-NHAC and NHAC by itself. In the immune response experiments, ADM-PLGA-NHAC exhibited remarkable biocompatibility. The in vivo antitumor experiment revealed that the implantation of ADM-PLGA-NHAC in the tumor resulted in a improved antineoplastic effect and fewer adverse side effects than direct intraperitoneal injection of ADM. The ADM-PLGA-NHAC developed in this study exhibited excellent extended-release drug properties, bone repairing and antineoplastic efficacy, which make it a promising osteoconductivity material with the capability to inhibit osteosarcoma.
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.|Department of Orthopaedics, Zhaoqing First People's Hospital, Zhaoqing, 526020, China.
authors.forename: Zi-Jie
authors.initials: ZJ
authors.lastname: Rong
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.|Department of Orthopaedics, Guangzhou Red Cross Hospital, Guangzhou, 510220, China.|Department of Orthopaedics, The Third Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510240, China.
authors.forename: Lian-Jun
authors.initials: LJ
authors.lastname: Yang
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.
authors.forename: Bao-Ta
authors.initials: BT
authors.lastname: Cai
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China. zhulixin1966@163.com.
authors.forename: Li-Xin
authors.initials: LX
authors.lastname: Zhu
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.
authors.forename: Yan-Lin
authors.initials: YL
authors.lastname: Cao
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.
authors.forename: Guo-Feng
authors.initials: GF
authors.lastname: Wu
authors.affiliation: Department of Orthopaedics, Zhu Jiang Hospital, Southern Medical University, No. 253, Gongye Big Road, Guangzhou, 510280, China.
authors.forename: Zan-Jie
authors.initials: ZJ
authors.lastname: Zhang
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000494:pharmacology; D001859:Bone Neoplasms / Q000188:drug therapy*; D045744:Cell Line, Tumor; D003094:Collagen / Q000737:chemistry*; D004317:Doxorubicin / Q000737:chemistry* / Q000494:pharmacology; D017886:Durapatite / Q000737:chemistry*; D005260:Female; D006801:Humans; D019344:Lactic Acid / Q000737:chemistry* / Q000494:pharmacology; D008297:Male; D051379:Mice; D008819:Mice, Nude; D049329:Nanostructures; D012516:Osteosarcoma; D011100:Polyglycolic Acid / Q000737:chemistry* / Q000494:pharmacology; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D054457:Tissue Scaffolds / Q000737:chemistry*
chemical_list: D000903:Antibiotics, Antineoplastic; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D004317:Doxorubicin; D003094:Collagen; D017886:Durapatite